Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-14T04:35:00.720Z Has data issue: false hasContentIssue false
  • English
  • Français

Flavimonas oryzihabitans (CDC Group Ve-2)

Published online by Cambridge University Press:  21 June 2016

Humayun J. Chaudhry ,
Paul E. Schoch  and
Burke A. Cunha
Humayun J. Chaudhry
Affiliation:
Infectious Disease Division and the Microbiology Laboratory, Winthrop-University Hospital, Mineola, New York, and the School of Medicine, SUNY at Stony Brook, Stony Brook, New York
Paul E. Schoch
Affiliation:
Infectious Disease Division and the Microbiology Laboratory, Winthrop-University Hospital, Mineola, New York, and the School of Medicine, SUNY at Stony Brook, Stony Brook, New York
Burke A. Cunha*
Affiliation:
Infectious Disease Division and the Microbiology Laboratory, Winthrop-University Hospital, Mineola, New York, and the School of Medicine, SUNY at Stony Brook, Stony Brook, New York
*
Infectious Disease Division, Winthrop-University Hospital, Mineola, NY 11501
Get access Rights & Permissions [Opens in a new window]

Extract

Flavimonas oryzihabitansis an uncommon organism with distinctive microbiological and biochemical features that is infrequently isolated from humans. The presence of foreign material, including indwelling intravascular catheters and artificial grafts, or various surgical procedures appear to predispose patients with underlying disease to bacteremic infection with Flavimonas. A gram-negative bacillus,F oryzihabitans is sensitive to most antibiotics except first- andsecond-generation cephalosporins.F oryzihabitans isolated from blood should be considered pathogenic in patients with indwelling catheters or prosthetic materials.

Previously designatedPseudomonasoryzihabitans and also known as Centers for Disease Control (CDC) Group Ve-2, F oryzihabitans is an unusual gram-negative, nonfermenting, oxidase-negative bacillus that is uncommonly associated with serious illness in humans.’ First described by Dresel and Stickl in 1928 and initially assigned the nameBacterium typhiflavum because of its similarity to the typhoid bacillus, the organism has been isolated from a variety of human sources, including blood, wounds, and abscesses, and (in mixed cultures) from sputum, urine, and cervical cultures.

Type
Topics in Clinical Microbiology
Information
Infection Control & Hospital Epidemiology , Volume 13 , Issue 8 , August 1992 , pp. 485 - 488
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Gilardi, GL, Hirschl, S, Mandel, M. Characteristics of yellow-pigmented non-fermentative bacilli (group Ve-1 and Ve-2) encountered in clinical bacteriology. J Clin Microbiol. 1975;1:384–389.CrossRefGoogle Scholar
2. Dresel, EG, Stickl, O. Ueber reversible mutatiensformen der typhusbazillen beim menschen. Dtsch Med Wochenschr. 1928;54:517–519.CrossRefGoogle Scholar
3. Freyney, J. Hansen, W, Etienne, J, et al. Postoperative infant septicemia caused by Pseudomonas luteola (CDC Group Ve-1) and Pseudomonas oryzihabitans (CDC Group Ve-2). J Clin Microbiol. 1988;26:1241–1243.CrossRefGoogle Scholar
4. Tatum, HW, Ewinh, WH, Weaver, RE. Miscellaneous gram-negative bacteria. In: Lennette, EH, Traunt, JP,eds. Manual of Clinical Microbiology, Washington, DC: American Society for Microbiology; 1974:270–294.Google Scholar
5. Pederson, MM,Marso, E, Pickett, MJ. Non fermentative bacilli associated with man: III. Pathogenicity and antibiotic susceptibility. Am J Clin Pathol. 1970;54:178–192.CrossRefGoogle Scholar
6. Gilardi, GL. Pseudomonas. In: Lennette, EH, Balows, A, Hausler, WJ, et al eds. Manual of Clinical Microbiology. 4th ed. Washington, DC: American Society for Microbiology; 1985:350–372.Google Scholar
7. Kodama, K, Kimura, K,Komagata, K. Two new species of Pseudomonas: P oryzihabitans isolated from a rice paddy, and P luteola isolated from clinical specimens. Intl J Syst Pact. 1985;35:467–474.CrossRefGoogle Scholar
8. Bendig, TWA. Mayes, PJ, Eyers, DE, et al. Flavimonas oryzihabitans (Pseudomonas oryzihabitans, CDC Group Ve-2): an emerging pathogen in peritonitis related to continuous ambulatory peritoneal dialysis? J Clin Microbiol. 1989;27:217–218.CrossRefGoogle ScholarPubMed
9. Pickett, MJ, Pederson, MM. Characterization of saccharolytic nonfermentative bacteria associated with man Can J Microbiol. 1970;16:351–362.Google Scholar
10. Holmes, B, Steigerwalt, AA,Weaver, RE, et al. Chryseomonas luteola comb. nov, and Flavimonas oryzihabitans gen. nov., comb, nov., Pseudomonas-like species from human clinical specimens and formerly known, respectively, as groups Ve-1 and Ve-2. Int J Syst Bact. 1987;37:245–250.CrossRefGoogle Scholar
11. Silver, MR, Felegie, TP, Sorkin, MI. Unusual bacterium, group Ve-2, causing peritonitis in a patient oncontinuous ambulatory peritoneal dialysis. J Clin Microbiol. 1985;21:838–839.CrossRefGoogle Scholar
12. Couetdic, G, Plesiat, P,Chambers, R,et al. Three cases of bacteremia species Ve-2 bacteria in France. Eur J Clin Microbiol. 1987;6:499–500.CrossRefGoogle Scholar
13. Gomez Garces, XL, Aguado, JM, Fernandez-Clua, MA, et al. Pseudomonas species Ve-2 septicemia. Eur J Clin Microbiol. 1986;5:168–169.CrossRefGoogle ScholarPubMed
14. Pien, FD. Group Ve-2 (Chromobacterium typhiflavum) bacteria . Clin Microbiol. 1977;6:435–436.CrossRefGoogle Scholar
15. Pien, FD, Chung, YS. Group Ve infection: case report of group Ve-2 septicemia and literature review . Diag Micro Infect Dis. 1986;5:177–180.CrossRefGoogle ScholarPubMed
16. Podbielski, A, Mertens, R,Ziebold, C, et al. Flavimonas oryzihabitans septicemia in a T-cell leukemic child: a case report and review of the literature. J Infect. 1990;20:135–141.CrossRefGoogle Scholar
17. Sobeck, KA,Kiehn, TE, Armstrong, D, et al. Sepsis caused by Flavimonas oryzihabitans in patients with neoplastic disease. Program of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy Los Angeles, Calif: American Society for Microbiology; 1988:226.Google Scholar
18. Conlu, A, Rothman, J, Staszewski, H, et al. Nosocomial Flavimonas oryzihabitans (CDC Group Ve-2) bacteremia associated with Hickman catheters, and a review of the literature. J Hosp Infect. 1992;20:293–300.CrossRefGoogle Scholar
19. Hawkins, RE, Moriarity, RA,Lewis, DE, et al. Serious infection involving the CDC group Ve bacteria Chryseomonas luteola and Flavimonas oryzihabitans . Rev Infect Dis. 1991;13:257–260.CrossRefGoogle ScholarPubMed
20. Amber, IJ, Reimer, LG. Pseudomonas, sp. group Ve2 bacterial peritonitis in a patient on continuous ambulatory peritoneal dialysis. J Clin Microbiol. 1987;25:744–745.CrossRefGoogle Scholar
21. Blumberg, DA, Cherry, JD. Agrobacterium radiobacter and CDC group VE-2 bacteremia. Diag Microbiol Infect Dis. 1989;12:351–355.CrossRefGoogle ScholarPubMed
22. Kostman, JR, Solomon, F, Fekete, T. Infections with Chryseomonas luteola (CDC Group Ve-1) and Flavimonas oryzihabitans (CDC Group Ve-2) in neurosurgical patients. Rev Infect Dis. 1991; 13:233–236.CrossRefGoogle Scholar
23. O’Leary, T, Fong, IW. Prosthetic valve endocarditis caused by group Ve-1 bacteria (Chromobacterium typhiflavum) . J Clin Microbiol. 1984;20:995.CrossRefGoogle Scholar
24. Doganay, M, Ozsan, K, Saygun, N. Pseudomonas-like bacteria group Ve biotype 1 isolated three times from subdiaphragmatic abscess. Mikrobiyol Bul. 1977;11:559–561.Google ScholarPubMed
25. Fass, RJ, Barnishan, J. In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis. 1980;2:841–853.CrossRefGoogle ScholarPubMed